Effects of metformin on contractility of isolated rat thoracic aorta
Abstract
Metformin is antihyperglycemic drug with antihypertensive property. In this study, the effects of metformin on the contractility of vascular smooth muscle of isolated rat aorta in the presence and absence of endothelium were investigated. The contactile response were measured isometrically. These results showed that metformin significantly inhibited the contraction induced by noradrenaline and caffeine. In addition, metformin directly caused significant vasodilation effect (p< 0.05). The percentage of maximal relaxation in endothelium-intact (32.96 +- 2.84 %, n = 16) was significantly higher than that of endothelium-denuded (14.93 +- 3.07 %, n = 7) (p< 0.05). In addition, methylene blue, atropine and L-NAME significantly inhibited the relaxant effect of metformin in endothelium-intact segment (p< 0.05). However indomethacin, propranolol, TEA, 4-AP and glibenclamide had no effect on metformin-mediated relaxation. In conclusion, metformin may affect vascular contractility by induced endothelium-dependent and endothelium-independent relaxation. Metformin-induced relaxation may be mediated direct activation of cholinergic receptor on the endothelium to initiate the NO-cGMP pathway.
How strong is the evidence?
Evidence Hub reads this as a thesis, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 16 participants or records.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.